Topical Ocular Povidone-Iodine as an Adjunctive Preventative Practice in the Era of COVID-19, T. O’Brien, J. Pelletier, Asia-Pacific Journal of Ophthalmology, March-April, 2021.
In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2, S. Frank, S. Brown, J. Capriotti, et al, JAMA Otolaryngology Head & Neck Surgery, September 17, 2020.
Tolerability of Halodine Oral and Nasal Antiseptics as Part of a SARS-CoV-2 Transmission Reduction Strategy, F. Chien, K. Stewart, K. Capriotti, and S. Amoakohene, Paripex – Indian Journal of Research, January 2021.
Effect of 1% Povidone Iodine Mouthwash/Gargle, Nasal and Eye Drop in COVID-19 Patient, M. Choudhury, N. Shabnam, T. Ahsan, et al, Bioresearch Communications, January 2021.
Prophylactic and therapeutic topical povidone‐iodine in coronavirus disease 2019 (COVID‐19): What is the evidence?, C. Yan and B. Bleier, International Forum of Allergy & Rhinology, October 29, 2020.
Nasal Povidone-Iodine Solutions Effectively Inactivate SARS-CoV-2 In Vitro, B. May, Pulmonology Advisor, September 30, 2020.
Efficacy of Povidone-Iodine Nasal And Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2), J. Pelletier, B. Tessema, J. Westover, S. Frank, S. Brown, and J. Capriotti, Ear, Nose & Throat Journal, September 21, 2020.
Reducing transmission of SARS-CoV-2 in ophthalmology with nasal and oral decontamination, J. Pelletier, K. Stewart, and B. Tessema, Therapeutic advances in ophthalmology, 2020.
Expanding the Role of Povidone-iodine in a COVID-19 Era, J. Pelletier, US Ophthalmic Review, August 21, 2020.
The Role of Povidone-Iodine in COVID-19, J. Pelletier, Touch Ophthalmology, August 2020.
Is povidone iodine mouthwash effective against SARS‐CoV‐2? First in vivo tests, L. Lamas, P. Dios, M. Rodríguez, V. Pérez, J. Alvargonzalez, A. Domínguez, J. Feijoo, M. Freitas, and J. Posse, Oral Diseases, July 2, 2020.
Antisepsis for Intravitreal Injections During the COVID-19 Pandemic, F. Chien and T. Leng, Retina Today, August 2020.
Chemical Considerations Related to the Dilution of Commercial 10% Povidone-Iodine for Use in the Covid-19 Pandemic, J. Pelletier, S. Amoakohene, and C. Nuckolls, Indian Journal of Research, 2020.
Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses, A. Bidra, J. Pelletier, J. Westover, S. Frank, S. Brown, and B. Tessema, Journal of Prosthodontics, 2020.
SARS-CoV-2 Viral Inactivation Using Low Dose Povidone-Iodine Oral Rinse—Immediate Application for the Prosthodontic Practice, B. Tessema, S. Frank, and A. Bidra, Journal of Prosthodontics, 2020.
Nasal and Oral Decontamination is Vital in Mitigating Spread of COVID-19, K. Capriotti, Journal of Clinical, Experimental and Cosmetic Dermatology, 2020.
Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era, S. Frank, J. Capriotti, S. Brown, and B. Tessema, Ear, Nose & Throat Journal, 2020.
Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse, A. Bidra, J. Pelletier, J. Westover, S. Frank, S. Brown, and B. Tessema, Journal of Prosthodontics, 2020.
Topical iodophor preparations: chemistry, microbiology, and clinical utility, K. Capriotti and J. Capriotti, Dermatology Online Journal, 2012.